CClinicalTrials.gg
CompletedNCT05982249Updated Oct 2, 2026

Hypnosis and Virtual Reality in Bone Marrow Examination

An interventional study of Hypnosis and Virtual reality (VR) in Hematologic Diseases, sponsored by Bnai Zion Medical Center. Completed at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Bnai Zion Medical Center · Not applicable, Interventional, and Supportive care

Updated Oct 2, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to compare the effects of hypnosis, virtual reality or their combination in patients undergoing a bone marrow procedure.

The main question it aims to answer is whether such interventions may relieve anxiety and other symptoms described by patients undergoing the procedure.

Before the bone marrow procedure and after being explained on the study and signing informed consent, the nurse will measure vital signs and participants will fill-out a 2-minutes' questionnaire and will be assigned to one of 3 groups:

  • Hearing a 7-minutes hypnotic script via earphones
  • Seeing and hearing virtual images and sounds via a virtual reality device during 7 minutes
  • None of these After these interventions or 10 minutes after assignation for patients not receiving intervention, patients will fill questionnaires again (about 5 minutes for filling the 2 questionnaires) and vital signs will be measured again. Then the bone marrow procedure will be performed. After the bone marrow procedure, the participants will fill-out another 2-minutes questionnaire and vital signs will be measured by the nurse.

Researchers will compare hypnotic script, virtual reality, their combination or none of them to see if they can affect anxiety and other complaints in patients undergoing a bone marrow procedure.

02

Conditions studied

  • Hematologic Diseases

Browse trials for

Keywords

  • Bone marrow
  • Procedure
  • Hematology
  • Hypnosis
  • Guided imagery
  • Virtual reality
03

In context

Hematologic Diseases

460 studies on the registry are indexed under Hematologic Diseases; 105 are open to participants now.

This study's enrollment of 67 is above the median of 50 across 274 interventional studies indexed under Hematologic Diseases.

Browse Hematologic Diseases studies →

Lead sponsor

Bnai Zion Medical Center is the lead sponsor of 102 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age 18 or older
  2. Candidate for a BM examination at the hematology unit
  3. Ability to answer questionnaires in Hebrew, Arabic or Russian
  4. Informed consent form signing

Exclusion criteria

Exclusion Criteria:

  1. Major hearing impairment
  2. Major visual impairment.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    Hypnosis (H)

    Patients will be given earphones to hear a hypnotic script that was recorded by Dr. Zahi Arnon, a psychologist specializing in hypnosis after observing about ten bone marrow (BM) examinations at the hematology institute. The length of the recording is about 7 minutes.

    Device: Hypnosis

  • Experimental
    Virtual reality (VR)

    Patients will be connected to a VR device that will transmit to the patient's choice a 3D screen and soothing noise for about 7 minutes.

    Device: Virtual reality (VR)

  • No intervention
    Control (C)

Interventions

  • DeviceHypnosis

    Patients will be given earphones to hear a hypnotic script that was recorded by Dr. Zahi Arnon, a psychologist specializing in hypnosis after observing about ten BM examinations at the hematology institute. The length of the recording is about 7 minutes.

  • DeviceVirtual reality (VR)

    Patients will be connected to a VR device that will transmit to the patient's choice a 3D screen and soothing noise for about 7 minutes.

06

What researchers measure

Primary outcomes

  1. Symptoms experienced by patients undergoing bone marrow procedure

    Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire: requires participants to nominate one or two concerns and, using a seven-point scale from 0 (worse outcome) to 6 (best outcome), to score these concerns and their general feeling of wellbeing

    Time frame: Through study completion, an average of 1 hour

Secondary outcomes

  1. Absorption, dissociation, immersion and time perception

    Validated questionnaire on absorption, dissociation, immersion and time perception

    Time frame: Through study completion, an average of 1 hour

  2. Sedation

    Type and dose of sedation used during procedure

    Time frame: Through study completion, an average of 1 hour

  3. Use of analgesics

    Type and dose of analgesics

    Time frame: Through study completion, an average of 1 hour

  4. Blood pressure

    Blood pressure

    Time frame: Through study completion, an average of 1 hour

  5. Pulse

    Pulse

    Time frame: Through study completion, an average of 1 hour

  6. Respiratory rate

    Respiratory rate

    Time frame: Through study completion, an average of 1 hour

07

Study locations

1 site
  • Bnai Zion Medical Center
    Haifa, 3339419, Israel
08

References and documents

Study documents

  • Study protocol · Jul 5, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 2, 2026
Primary completion
Jul 2026→Sep 1, 2025 (actual)
Oct 2, 2026
Study completion
Jul 2026→Sep 1, 2025 (actual)
Oct 2, 2026
Enrollment
100 (estimated)→67 (actual)
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Recruiting→Completed
    Primary completion Jul 2026→Sep 1, 2025 (now actual)
    Study completion Jul 2026→Sep 1, 2025 (now actual)
    Enrollment 100 (estimated)→67 (actual)
    + 4 other changes: index terms, verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05982249
Lead sponsor
Bnai Zion Medical Center
Responsible party
Sponsor
First posted
Aug 8, 2023
Start date
Jul 13, 2023
Primary completion
Sep 1, 2025
Completion
Sep 1, 2025
Last update
Oct 2, 2026

Study contacts

Ilana Levy Yurkovski, MD
principal investigator · Bnai Zion Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion